| scholarly article | Q13442814 |
| P50 | author | Orestis A. Panagiotou | Q42589634 |
| John Ioannidis | Q6251482 | ||
| P433 | issue | 21 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | citation analysis | Q206276 |
| meta-analysis | Q815382 | ||
| biomarker | Q864574 | ||
| P304 | page(s) | 2200-2210 | |
| P577 | publication date | 2011-06-01 | |
| P1433 | published in | The Journal of the American Medical Association | Q1470970 |
| P1476 | title | Comparison of effect sizes associated with biomarkers reported in highly cited individual articles and in subsequent meta-analyses | |
| P478 | volume | 305 |
| Q57413870 | 2013 ACC/AHA Guideline on the Assessment of Cardiovascular Risk |
| Q36429024 | 2013 ACC/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines |
| Q37967642 | A statistician's perspective on biomarkers in drug development. |
| Q28078495 | Aneuploidy: a common and early evidence-based biomarker for carcinogens and reproductive toxicants |
| Q38077526 | Appropriate Use Criteria for Amyloid PET: A Report of the Amyloid Imaging Task Force, the Society of Nuclear Medicine and Molecular Imaging, and the Alzheimer’s Association |
| Q37069527 | Appropriate use criteria for amyloid PET: A report of the Amyloid Imaging Task Force, the Society of Nuclear Medicine and Molecular Imaging, and the Alzheimer's Association |
| Q37975150 | Association Between Type D Personality and Prognosis in Patients with Cardiovascular Diseases: a Systematic Review and Meta-analysis |
| Q38837595 | Bias in emerging biomarkers for bipolar disorder |
| Q62496796 | Big Data in traumatic brain injury; promise and challenges |
| Q38088378 | Bioinformatics advances for clinical biomarker development |
| Q37944364 | Biomarkers for diabetes prediction, pathogenesis or pharmacotherapy guidance? Past, present and future possibilities |
| Q35471494 | Biomarkers: hopes and challenges in the path from discovery to clinical practice. |
| Q34466108 | Biospecimens, biomarkers, and burgeoning data: the imperative for more rigorous research standards |
| Q43740352 | By Desperate Appliance Relieved? On the Clinical Relevance of Risk Stratification to Therapeutic Decision-Making |
| Q35879887 | Cancer biomarker discovery and validation |
| Q26864429 | Cancer biomarkers |
| Q35078580 | Challenges in the development of an immunochromatographic interferon-gamma test for diagnosis of pleural tuberculosis |
| Q38976987 | Clinical Applications of Next-Generation Sequencing in Cancer Diagnosis |
| Q24289183 | Clinical Outcome Prediction by MicroRNAs in Human Cancer: A Systematic Review |
| Q50073721 | Clinicopathological and prognostic significance of blood microvessel density in endometrial cancer: a meta-analysis and subgroup analysis. |
| Q58799464 | Clinicopathological and prognostic significance of long noncoding RNA MALAT1 in human cancers: a review and meta-analysis |
| Q33738829 | Current and future management of diabetic retinopathy: a personalized evidence-based approach |
| Q38234228 | Current status of molecular biomarkers in endometrial cancer |
| Q21129393 | Deep impact: unintended consequences of journal rank |
| Q34625519 | Detailed analysis of gene polymorphisms associated with ischemic stroke in South Asians |
| Q34583298 | Discovery of novel biomarkers and phenotypes by semantic technologies |
| Q44756365 | Does television reflect the evolution of scientific knowledge? The case of attention deficit hyperactivity disorder coverage on French television |
| Q64061066 | Dynamic multi-outcome prediction after injury: Applying adaptive machine learning for precision medicine in trauma |
| Q35622059 | Early developments in gene-expression profiling of breast tumors: potential for increasing black-white patient disparities in breast cancer outcomes? |
| Q34141675 | Evaluation of a previously suggested plasma biomarker panel to identify Alzheimer's disease |
| Q40233002 | Exposure-wide epidemiology: revisiting Bradford Hill |
| Q42569059 | Galectin-3 and new-onset CKD: marker or mediator? |
| Q38033463 | Genetic polymorphisms and traumatic brain injury: the contribution of individual differences to recovery |
| Q37991924 | Genetic polymorphisms influence recovery from traumatic brain injury |
| Q38068540 | Genetic risk factors for drug-induced liver injury in rheumatoid arthritis patients using low-dose methotrexate. |
| Q38080879 | Highly Multiplexed Proteomic Platform for Biomarker Discovery, Diagnostics, and Therapeutics |
| Q48926338 | Hot topics in functional neuroradiology. |
| Q57711927 | How to get proteomics to the clinic? Issues in clinical proteomics, exemplified by CE‐MS |
| Q61817202 | Impact of epidural analgesia on the systemic biomarker response after hepatic resection |
| Q36297774 | Implementation of proteomic biomarkers: making it work |
| Q44784034 | Important achievements in the search for psychopathological predictors, but still a long road ahead: editorial comment to Baldessarini RJ, Undurraga J, Vazquez GH et al. 'Predominant recurrence polarity among 928 adult international bipolar-I-disord |
| Q42112095 | Improving Validation Practices in “Omics” Research |
| Q37001346 | Improving risk classification of critical illness with biomarkers: a simulation study |
| Q104111087 | Increasing the reproducibility of fluid biomarker studies in neurodegenerative studies |
| Q36420861 | Increasing value and reducing waste in research design, conduct, and analysis |
| Q37940788 | Integrating predictive biomarkers and classifiers into oncology clinical development programmes |
| Q35153779 | International trends in health science librarianship Part 9: the UK - Scotland and Wales |
| Q35150183 | Investigation of blood mRNA biomarkers for suicidality in an independent sample |
| Q38191496 | Is individualized medicine more cost-effective? A systematic review |
| Q102384306 | Laboratory-wide association study of survival with prostate cancer |
| Q26746258 | Long noncoding RNAs as novel predictors of survival in human cancer: a systematic review and meta-analysis |
| Q30540746 | MRI and cerebrospinal fluid biomarkers for predicting progression to Alzheimer's disease in patients with mild cognitive impairment: a diagnostic accuracy study |
| Q38173896 | Mechanism of inflammation in age-related macular degeneration: an up-to-date on genetic landmarks. |
| Q34685896 | MicroRNA signatures as biomarkers and therapeutic target for CNS embryonal tumors: the pros and the cons |
| Q27013998 | MicroRNAs as biomarkers for CNS disease |
| Q24289470 | Molecular phenotyping of a UK population: defining the human serum metabolome |
| Q36070049 | Multiple biomarkers for risk prediction in chronic heart failure. |
| Q37970510 | Negative results: why do they need to be published? |
| Q30393882 | New Perspectives on How to Discover Drugs from Herbal Medicines: CAM's Outstanding Contribution to Modern Therapeutics. |
| Q34500043 | No diagnostic value of plasma clusterin in Alzheimer's disease |
| Q57790342 | Overinterpretation and misreporting of prognostic factor studies in oncology: a systematic review |
| Q86033611 | Personalized therapy in cardiology. Biomarkers, pharmacogenetics and therapy of monogenic diseases |
| Q38056125 | Perspectives of Integrative Cancer Genomics in Next Generation Sequencing Era |
| Q33845324 | Polygenic risk predicts obesity in both white and black young adults |
| Q36286246 | Poor replication validity of biomedical association studies reported by newspapers |
| Q27007436 | Predictive accuracy of amyloid imaging for progression from mild cognitive impairment to Alzheimer disease with different lengths of follow-up: a meta-analysis. [Corrected |
| Q92885087 | Proenkephalin A Adds No Incremental Prognostic Value After Acute Ischemic Stroke |
| Q52802632 | Prognostic DNA methylation markers for sporadic colorectal cancer: a systematic review |
| Q24289043 | Prognostic effect size of cardiovascular biomarkers in datasets from observational studies versus randomised trials: meta-epidemiology study |
| Q85067275 | Prospective Registration of Marker Evaluation Studies: Time to Act |
| Q28730650 | Protein signature of lung cancer tissues |
| Q24289453 | Quantifying the value of biomarkers for predicting mortality |
| Q38254343 | Rediscovery rate estimation for assessing the validation of significant findings in high-throughput studies |
| Q28597442 | Replication Validity of Initial Association Studies: A Comparison between Psychiatry, Neurology and Four Somatic Diseases |
| Q38097339 | Review of the cost effectiveness of pharmacogenetic-guided treatment of hypercholesterolaemia |
| Q38400917 | SOT/EUROTOX Debate: Biomarkers From Blood and Urine Will Replace Traditional Histopathological Evaluation to Determine Adverse Responses |
| Q56525330 | STrengthening the Reporting of OBservational studies in Epidemiology - Molecular Epidemiology (STROBE-ME): An extension of the STROBE statement |
| Q56525359 | STrengthening the Reporting of OBservational studies in Epidemiology - Molecular Epidemiology (STROBE-ME): An extension of the STROBE statement |
| Q56525808 | STrengthening the Reporting of OBservational studies in Epidemiology — Molecular Epidemiology (STROBE-ME): An extension of the STROBE statement |
| Q34062156 | STrengthening the Reporting of OBservational studies in Epidemiology--Molecular Epidemiology (STROBE-ME): an extension of the STROBE Statement |
| Q56525829 | STrengthening the reporting of OBservational studies in Epidemiology—Molecular Epidemiology (STROBE-ME): an extension of the STROBE statement |
| Q24273236 | Scientific Utopia: II. Restructuring Incentives and Practices to Promote Truth Over Publishability |
| Q36146914 | Serum IL-17F does not predict poor response to IM IFNβ-1a in relapsing-remitting MS |
| Q47152409 | Small sample sizes in high-throughput miRNA screens: A common pitfall for the identification of miRNA biomarkers. |
| Q86877976 | Social Integration, Social Support and Mortality in the US National Health Interview Survey |
| Q41357862 | Soluble ST2 predicts outcome and hemorrhagic transformation after acute stroke |
| Q28652312 | State of the art review: the data revolution in critical care |
| Q36239075 | Study designs and statistical analyses for biomarker research |
| Q35917499 | Survival in daily home hemodialysis and matched thrice-weekly in-center hemodialysis patients |
| Q26824124 | Systems biology approaches for discovering biomarkers for traumatic brain injury |
| Q88433162 | The Microbiome and Biomarkers for Necrotizing Enterocolitis: Are We Any Closer to Prediction? |
| Q55315552 | The early economic evaluation of novel biomarkers to accelerate their translation into clinical applications. |
| Q34485871 | The implications of biomarker evidence for systematic reviews |
| Q35555999 | The influence of social context on the treatment outcomes of complementary and alternative medicine: the case of acupuncture and herbal medicine in Japan and the U.S. |
| Q28658972 | The power of meta-analysis in genome-wide association studies |
| Q38009054 | The proteomic future: where mass spectrometry should be taking us. |
| Q30490659 | The statistical crisis in science: how is it relevant to clinical neuropsychology? |
| Q89792972 | Tissue Infiltrating Immune Cells as Prognostic Biomarkers in Endometrial Cancer: A Meta-Analysis |
| Q36779120 | Towards the identification of blood biomarkers for acute stroke in humans: a comprehensive systematic review |
| Q35694362 | Translational genomics: the challenge of developing cancer biomarkers |
| Q48693004 | Type D Personality and Heart Disease: Walking the Line Between Enthusiasm and Disbelief |
| Q37994418 | Using biomarkers in sewage to monitor community-wide human health: Isoprostanes as conceptual prototype |
| Q36081775 | What Matters Most for Predicting Survival? A Multinational Population-Based Cohort Study |
| Q38028668 | Why Are Some Studies of Cardiovascular Markers Unreliable? The Role of Measurement Variability and What an Aspiring Clinician Scientist Can Do Before It Is Too Late |
| Q24288708 | Why most biomedical findings echoed by newspapers turn out to be false: the case of attention deficit hyperactivity disorder |
| Q38623016 | miRNAs as Circulating Biomarkers for Alzheimer's Disease and Parkinson's Disease. |
Search more.